Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
allogeneic adipose derived mesenchymal stem cell (1 trial)
autologous adipose-derived mesenchymal stem cells (2 trials)
Multiple Sclerosis (Phase 1)
Sclerosis (Phase 1)
Trials (3 total)
Trial APIs (2 total)